Literature DB >> 2492539

Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations.

M M Reddy1, M Lange, M H Grieco.   

Abstract

Soluble CD8 levels in sera were quantitated in asymptomatic intravenous drug abusers, homosexuals, and patients with lymphadenopathy or acquired immunodeficiency syndrome. Soluble CD8 levels were elevated in human immunodeficiency virus-seronegative intravenous drug abusers and homosexuals, probably reflecting infections like cytomegalovirus. The sera of human immunodeficiency virus-seropositive groups of patients with human immunodeficiency virus infection also had elevated levels of soluble CD8, reflecting infections like cytomegalovirus and human immunodeficiency virus infection.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2492539      PMCID： PMC267287          DOI： 10.1128/jcm.27.2.257-260.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

1.  Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome.

Authors:  D E Lewis; J M Puck; G F Babcock; R R Rich
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

Review 2.  The immunoglobulin superfamily--domains for cell surface recognition.

Authors:  A F Williams; A N Barclay
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

3.  Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy.

Authors:  E DeStefano; R M Friedman; A E Friedman-Kien; J J Goedert; D Henriksen; O T Preble; J A Sonnabend; J Vilcek
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

4.  Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies.

Authors:  M De Waele; C Thielemans; B K Van Camp
Journal:  N Engl J Med       Date:  1981-02-19       Impact factor: 91.245

5.  The role of T cell differentiation markers in antigen-specific and lectin-dependent cellular cytotoxicity mediated by T8+ and T4+ human cytotoxic T cell clones directed at class I and class II MHC antigens.

Authors:  H Spits; J Borst; C Terhorst; J E de Vries
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

6.  Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.

Authors:  S H Weiss; J J Goedert; M G Sarngadharan; A J Bodner; R C Gallo; W A Blattner
Journal:  JAMA       Date:  1985-01-11       Impact factor: 56.272

7.  Elevated beta 2-microglobulin and lysozyme levels in patients with acquired immune deficiency syndrome.

Authors:  M H Grieco; M M Reddy; H B Kothari; M Lange; E Buimovici-Klein; D William
Journal:  Clin Immunol Immunopathol       Date:  1984-08

8.  Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders.

Authors:  J L Fahey; H Prince; M Weaver; J Groopman; B Visscher; K Schwartz; R Detels
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

9.  Immunochemical analysis of the released Leu-2 (T8) molecule.

Authors:  J Fujimoto; S J Stewart; R Levy
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

10.  Spontaneous release of the Leu-2 (T8) molecule from human T cells.

Authors:  J Fujimoto; S Levy; R Levy
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307
View more
  10 in total

1.  Serum soluble CD4, CD8 and IL-2R levels in adult acute myeloid leukemia in remission.

Authors:  Y Iizuka; M Aiso; T Ohshima; S Sawada; T Horie
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

2.  Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency.

Authors:  M E North; G P Spickett; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

3.  Serum soluble CD4 and CD8 levels in Kawasaki disease.

Authors:  S Furukawa; T Matsubara; K Tsuji; T Motohashi; K Okumura; K Yabuta
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

4.  CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells.

Authors:  M Labalette; F Salez; F R Pruvot; C Noel; J P Dessaint
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

5.  Neopterin and alpha and beta interleukin-1 levels in sera of patients with human immunodeficiency virus infection.

Authors:  M M Reddy; M H Grieco
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

6.  Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children?

Authors:  M M Chan; J M Campos; S Josephs; N Rifai
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

7.  Serum markers of T cell activation in relapses of Wegener's granulomatosis.

Authors:  C A Stegeman; J W Tervaert; M G Huitema; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

8.  Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes.

Authors:  A Kalinkovich; G Livshits; H Engelmann; N Harpaz; R Burstein; M Kaminsky; D Wallach; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

9.  Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis.

Authors:  G Vitale; C Mocciaro; R Malta; G Gambino; A Spinelli; C Giordano; G Stassi; F Arcoleo; S Milano; E Cillari
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

10.  Elevated levels of CD4 antigen in sera of human immunodeficiency virus-infected populations.

Authors:  M M Reddy; M Vodian; M H Grieco
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.